Zobrazeno 1 - 10
of 562
pro vyhledávání: '"GUCHELAAR, HJ"'
Autor:
Diekstra, MH, Fritsch, A, Kanefendt, F, Swen, JJ, Moes, DJAR, Sörgel, F, Kinzig, M, Stelzer, C, Schindele, D, Gauler, T, Hauser, S, Houtsma, D, Roessler, M, Moritz, B, Mross, K, Bergmann, L, Oosterwijk, E, Kiemeney, LA, Guchelaar, HJ, Jaehde, U
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology; Sep2017, Vol. 6 Issue 9, p604-613, 10p
Autor:
Swen, J. J., Nijenhuis, M., de Boer, A, Grandia, AH, Mulder, H, Maitland-van der Zee, A. H., Rongen, GA, van Schaik, RHN, Schalekamp, T, Touw, Daan, van der Weide, J, Wilffert, Bob, Deneer, VHM, Guchelaar, HJ
Publikováno v:
Pharmaceutische Weekblad Wetenschappelijk Platform, 5(6). Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d6c2fbac04b39cbbdbd5a6ea9afbced8
https://research.rug.nl/en/publications/6557910b-9623-404c-941c-48c9ae059c00
https://research.rug.nl/en/publications/6557910b-9623-404c-941c-48c9ae059c00
Autor:
van Hattem, S (Simone), Aarts, MJ, Louwman, Woutera, Neumann, HAM, Coebergh, Jan Willem, Looman, Caspar, Koomen, ER, Joosse, Arjen, Herings, RMC (Ron), Casparie, MK, Guchelaar, HJ, Nijsten, Tamar
Publikováno v:
Melanoma Research, 9, 327-332. Lippincott Williams & Wilkins (Wolters Kluwer)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::535cb230cc5df09fb29889b2ef70c01c
https://pure.eur.nl/en/publications/9f8d4526-e324-4c62-9c0b-ece61ec695b4
https://pure.eur.nl/en/publications/9f8d4526-e324-4c62-9c0b-ece61ec695b4
Publikováno v:
Arthritis & Rheumatism, 56(2), 694-695. John Wiley & Sons Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::5674f28543f3715fb96e0ef94351ccf4
https://pure.eur.nl/en/publications/80174e40-aa4e-4819-9424-ec811238d80e
https://pure.eur.nl/en/publications/80174e40-aa4e-4819-9424-ec811238d80e
Publikováno v:
Pharmacy World & Science, 20(1), 43-44. Kluwer Academic Publishers
A case is presented of reversible acute hepatitis in a patient using a Chinese herbal tea. Upon identification of the tea mixture Aristolochia species, including A. debilis, which contains the highly toxic aristolochic acid, could be identified. We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::8cbc49f981cf5eaa452661c6a967ae19
https://research.rug.nl/en/publications/7b6b3953-08b9-4c58-9122-17e123a7cb11
https://research.rug.nl/en/publications/7b6b3953-08b9-4c58-9122-17e123a7cb11
Autor:
GIETEMA, JA, VELDHUIS, GJ, GUCHELAAR, HJ, WILLEMSE, PHB, UGES, DRA, CATS, A, VANDERGRAAF, WTA, SLEIJFER, DT, DEVRIES, EGE, MULDER, NH, Boonstra, J.
Publikováno v:
British Jounal of Cancer, 71(6), 1302-1307. Nature Publishing Group
Tn phase I studies, lobaplatin showed activity in ovarian cancer patients pretreated with platinum. A phase II trial with lobaplatin was performed in patients with refractory or relapsed ovarian cancer to define activity and pharmacokinetics. Twenty-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::93e687aceba17e08c2a461ceff07e01e
https://research.rug.nl/en/publications/26771bd8-b705-43da-9328-fd534322c7ff
https://research.rug.nl/en/publications/26771bd8-b705-43da-9328-fd534322c7ff
Publikováno v:
Pharmaceutical Research, 11(9), 1265-1269. SPRINGER/PLENUM PUBLISHERS
The importance of the ultrafilterable platinum (fPt) fraction of cisplatin (CDDP) and carboplatin (CBDCA) for cytotoxicity and myelotoxicity was studied in vitro. By incubating CDDP or CBDCA with fetal calf serum (FCS) various fractions of fPt were p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::fbd92acb7884c89499e1819235041e35
https://research.rug.nl/en/publications/27856391-2700-41fe-bf07-d4c52d70c38b
https://research.rug.nl/en/publications/27856391-2700-41fe-bf07-d4c52d70c38b
Publikováno v:
Anti-Cancer Drugs, 4(1), 51-55. LIPPINCOTT WILLIAMS & WILKINS
A phase I trial with continuous intravenous infusion of lobaplatin (D-19466; 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate) for 72 h was performed to determine the maximum tolerated dose (MTD). Each patient received a single dose level, the to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::9b74b1813b0e67ea7e8c408646ee04eb
https://research.rug.nl/en/publications/d08b58d1-3910-4217-a117-4a07d24cd6c8
https://research.rug.nl/en/publications/d08b58d1-3910-4217-a117-4a07d24cd6c8
Publikováno v:
Pharmaceutical Research, 9(6), 808-811. SPRINGER/PLENUM PUBLISHERS
The chemical stability of the new anticancer platinum analogue 1,2-diaminomethyl-cyclobutane-platinum(II)-lactate (D19466) in infusion media was studied in an accelerated stability testing experiment with a selective HPLC-UV method. Variables were ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::33503481eb63cebd938c0868fed2ed53
https://research.rug.nl/en/publications/f0035628-44a3-4cf8-8bee-3505a7c386d8
https://research.rug.nl/en/publications/f0035628-44a3-4cf8-8bee-3505a7c386d8
Autor:
Charehbili, A, Groot, S de, der Straaten, T van, Swen, JJ, Pijl, H, Gelderblom, H, de Velde, CJH van, Nortier, JWR, Guchelaar, HJ, Kroep, JR
Publikováno v:
Pharmacogenomics; Jul2015, Vol. 16 Issue 11, p1265-1274, 10p